34 Universities in Canada offering Biotechnology degrees and coursesBrock UniversityCarleton UniversitySeneca PolytechnicConestoga CollegeCentennial
Feb 10, 2020Examples of biotechnology-derived products regulated by Health Canada are genetically modified and other novel foods, biologics and genetic
Is Canada good for biotechnology? Yes, Canada is a world leader in biotechnology and has a large network in universities, research hospitals, laboratories, and companies that work within four significant sectors.
Is Canada a good place to invest in biotechnology?
Canada is internationally well positioned in this field, as it now accounts for almost 10% of the world's biotechnology-related revenues and ranks second behind the US in number of biotechnology firms.
The federal government has made significant efforts and investments to support the development of biotechnology.
Overview
The Canadian Biotechnology Strategy (CBS) is Canada's plan for the emerging field of biotechnology that supports and compliments the regulatory and research activities of various federal departments and agencies.
The CBS is rooted in the late 70's when a task force, composed of industry and academia was set up to determine how to facilitate the potential of new recombinant DNA techniques that were coming out at the time.
In 1983 the National Biotechnology Strategy (NBS) was created to develop biotechnology to enhance economic, health and environmental benefits to Canada.
Smart Regulations and Biotechnology
The Canadian government established the External Advisory Committee on Smart Regulation (EACSR) in May 2003.
The Committee was asked to provide the government with an external perspective and expert advice on the best way to redesign the government's regulatory approach to create and maintain a Canadian advantage.
What is Biote Canada?
BIOTECanada is the national industry association and lead voice with over 200 members of the ecosystem located nationwide, reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors.
Want to meet the companies attending BIO 2023? .
What is the Canadian biotechnology strategy (CBS)?
The Canadian Biotechnology Strategy (CBS) is Canada's plan for the emerging field of biotechnology that supports and compliments the regulatory and research activities of various federal departments and agencies.
InNexus Biotechnology, Inc.. was a drug company based in British Columbia, Canada.
InNexus was founded in 2001 and became a publicly traded corporation in 2003 on the TSX Venture Exchange.
On 2009-12-30, the company filed a Form 15-F with the U.
S.
Securities and Exchange Commission (SEC) to voluntarily deregister its common stock under the Securities Exchange Act of 1934 and continue its primary listing on the TSX Venture Exchange under the symbol of IXS; it is no longer listed on the TSX Venture Exchange.
IXS was developing what they refer to as DXLA- or DXL-modified antibodies, wherein certain autophilic peptides are integrated with a monoclonal antibody.
The DXL-modified antibodies have been shown to have enhanced binding affinity and, as a potential result, greater potency for use as a therapy to fight cancer and higher signal strength for use as a diagnostic for detecting cancer versus an unmodified antibody.
